Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04547712 · ClinicalTrials.gov registry record · NA
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease
A NA study, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT04547712 is a NA study that has completed, run by MedtronicNeuro. The registered enrollment target is 85 participants.
The verdict
NCT04547712, a NA study, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
The purpose of the study is to demonstrate the safety and effectiveness of adaptive DBS (aDBS) for Parkinson's disease.
Interventions
- DEVICE Adaptive DBS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2020-12-14 |
| Est. Completion | 2025-05-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04547712
The ClinicalTrials.gov registry entry for NCT04547712 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adaptive DBS is the first listed.
NCT04547712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04547712 about?
NCT04547712 is a clinical study titled "Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease". The purpose of the study is to demonstrate the safety and effectiveness of adaptive DBS (aDBS) for Parkinson's disease.
What is the current status of trial NCT04547712?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2020-12-14. Estimated completion is 2025-05-02.
What interventions are being tested in trial NCT04547712?
The interventions under investigation include: Adaptive DBS (DEVICE).
Who is sponsoring clinical trial NCT04547712?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.